Founded in 1849, Pfizer is a global pharmaceutical company dedicated to discovering and developing safe, effective, and affordable medicines. With a broad portfolio across various therapeutic areas, Pfizer focuses on wellness, prevention, treatment, and cures for diseases, including investments in emerging technologies to shape the future of healthcare.
Chief Oncology Officer and Executive Vice President
Barbara Dalton
Vice President
Tina Deignan
President of Oncology Commercial
Past deals in Rhode Island
Mind Immune Therapeutics
Series A in 2022
MindImmune Therapeutics is a pharmaceutical company that develops antibody-based therapies targeting the immune system to treat diseases of the central nervous system. Its programs aim to address neuroinflammation associated with brain disorders such as Alzheimer's disease, Huntington's disease, pain, and psychiatric conditions. The company emphasizes the role of immune dysfunction in CNS pathology and seeks to inhibit peripheral innate immune responses to produce therapeutic effects. Based in Kingston, Rhode Island, MindImmune pursues collaborations with neuroscience research institutions to advance its drug development initiatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.